Purine analogs (fludarabine and 2-chlorodeoxyadenosine) as apoptosis-inducing drugs in CML therapy.

نویسندگان

  • G Martinelli
  • P L Zinzani
  • P Farabegoli
چکیده

Fludarabine (Flu) and 2-chlorodeoxyadenosine (2-CdA) are purine analogs with antineoplastic activity in lymphoproliferative malignancies. We recently showed in vitro the effective role of Flu and 2-CdA in the activation of apoptosis. We observed a dramatic induction of apoptosis in vitro by Flu (Figure 1) and 2-CdA on fresh CML cells, with or without the association of IFN-a. The mechanism behind this is at present unknown, but in vivo studies have also suggested therapeutic roles for Flu and 2-CdA in CML patients. We think that programmed cell death may be suppressed in cells carrying the bcr-abl transcript and that Flu and 2-CdA might remove this suppression effect in the neoplastic cell cycle. McGahon et al. reported that K562, a chronic myelogenous leukemia (CML) cell line expressing the BCR-ABL fusion protein, is resistant to the induction of apoptosis by a number of agents and conditions. They indicate that BCRABL acts as an anti-apoptosis gene in CML and suggest that the effect is dependent on this chimeric protein. CML cells may also resist the effects of cytotoxic agents by overexpression of apoptosis-suppressing genes such as bcl-2 or ras. These observations indicate that the myeloid expansion in CML may occur via prolongation of cell survival and that the elevated expression of BCR-ABL tyrosine kinase activity may act to suppress apoptosis. They conclude that an antisense approach to inhibit the expression of the apoptosis-suppressing gene in combination with standard chemotherapy may offer a new therapeutic strategy in conditions in which suppression of apoptosis contributes to the development of the malignancy. In CML cells such as the K562 cell line, due to

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Apoptosis induction with purine analogs on freshly isolated chronic myeloid leukemia cells.

chronic myeloid leukemia (CML) is a myeloproliferative disorder with an average duration of 3 years. The fatal course CML patients on conventional therapy (including radiation, splenectomy and chemotherapy) has prompted an investigation of new treatments for the chronic phase of the disease because allogeneic bone marrow transplantation, the only potentially curative treatment modality known, i...

متن کامل

Purine Analogs for the Treatment of Low-Grade Lymphoproliferative Disorders.

PRIMARY PURPOSE: Low-grade lymphoproliferative disorders follow an indolent clinical course but are incurable with current therapy. Recently, three active agents for the treatment of these diseases have been identified: the purine analogs fludarabine, pentostatin and 2-chlorodeoxyadenosine. The purpose of this review is to summarize the current knowledge on the mechanism of action, clinical act...

متن کامل

Apoptosis induction with fludarabine on freshly isolated chronic myeloid leukemia cells.

BACKGROUND Fludarabine (FLU) is a fluorinated purine analogue with antineoplastic activity in lymphoproliferative malignancies. Recently, some in vitro reports have showed the effective role of FLU on the activation of apoptosis. MATERIALS AND METHODS The induction of programmed cell death (apoptosis) by fludarabine (FLU), an adenine nucleoside analogue, alpha-interferon (alpha-IFN), and FLU ...

متن کامل

Purine nucleoside analogs: emerging roles in indolent lymphoproliferative disorders.

R ECENTLY, a great deal of interest has been generated in three new purine nucleoside analogs because of their remarkable activity in a variety of incurable malignant lymphoproliferative disorders. 2-Fluoro-ara-AMP (fludarabine), 2-deoxycoformycin (ZDCF, pentostatin), and 2-chlorodeoxyadenosine (2-CdA) are all structurally similar analogs of adenosine, but they differ in their interaction with ...

متن کامل

In vitro sensitivity of chronic lymphocytic leukemia B-cells to fludarabine, 2-chlorodeoxyadenosine and chlorambucil: correlation with clinico-hematological and immunophenotypic features.

BACKGROUND Chlorambucil (CLB), 2-chlorodeoxyadenosine (2-CDA) and fludarabine (FAMP) are among the most widely used drugs in chronic lymphocytic leukemia (CLL). Therefore we evaluated in vitro sensitivity to these drugs and cross-resistance of purine analogs. In addition, we correlated the in vitro data with the main clinico-hematological variables and surface markers. PATIENTS AND METHODS Ei...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Haematologica

دوره 81 3  شماره 

صفحات  -

تاریخ انتشار 1996